Intrinsic Value of S&P & Nasdaq Contact Us

Aurora Spine Corporation ASAPF OTC

Other OTC • Healthcare • Medical - Devices • CA • USD

SharesGrow Score
33/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aurora Spine Corporation (ASAPF) generated $860.91K in operating cash flow for fiscal year 2024. After capital expenditures of $388.91K, free cash flow was $472K.

Free cash flow margin was 2.8% of revenue. Cash conversion ratio was -0.9x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (14/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was -0.9x suggests some earnings are non-cash items

Overall SharesGrow Score: 31/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
33/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
14/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
10/100
→ Income
Aurora Spine Corporation Cash Flow History
Metric TTM FY2024 FY2023 FY2022 FY2021
Operating Cash Flow $557.28K$860.91K$-935.06K$-1.56M$-2.13M
Capital Expenditure $-443.18K$-388.91K$-479.13K$-873.21K$-720.61K
Free Cash Flow $114.1K$472K$-1.41M$-2.43M$-2.85M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message